These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298 [TBL] [Abstract][Full Text] [Related]
23. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique. Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128 [TBL] [Abstract][Full Text] [Related]
24. (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells. Richter S; Bouvet V; Wuest M; Bergmann R; Steinbach J; Pietzsch J; Neundorf I; Wuest F Nucl Med Biol; 2012 Nov; 39(8):1202-12. PubMed ID: 22784382 [TBL] [Abstract][Full Text] [Related]
25. Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models. Bouvet V; Wuest M; Jans HS; Janzen N; Genady AR; Valliant JF; Benard F; Wuest F EJNMMI Res; 2016 Dec; 6(1):40. PubMed ID: 27142881 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 2-amino-5-(4-[(18)F]fluorophenyl)pent-4-ynoic acid ([(18)F]FPhPA): a novel (18)F-labeled amino acid for oncologic PET imaging. Way JD; Wang M; Hamann I; Wuest M; Wuest F Nucl Med Biol; 2014 Sep; 41(8):660-9. PubMed ID: 24993371 [TBL] [Abstract][Full Text] [Related]
28. Ardipradja KS; Wichmann CW; Hickson K; Rigopoulos A; Alt KM; Pearce HA; Wang X; O'Keefe G; Scott AM; Peter K; Hagemeyer CE; Ackermann U Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805892 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET. Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer. Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647 [TBL] [Abstract][Full Text] [Related]
31. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments. Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306 [TBL] [Abstract][Full Text] [Related]
33. Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer. Möbus VJ; Baum RP; Bolle M; Kreienberg R; Noujaim AA; Schultes BC; Nicodemus CF Am J Obstet Gynecol; 2003 Jul; 189(1):28-36. PubMed ID: 12861134 [TBL] [Abstract][Full Text] [Related]
34. Antiidiotype induction therapy: evidence for the induction of immune response through the idiotype network in patients with ovarian cancer after administration of anti-CA125 murine monoclonal antibody B43.13. Madiyalakan R; Sykes TR; Dharampaul S; Sykes CJ; Baum RP; Hör G; Noujaim AA Hybridoma; 1995 Apr; 14(2):199-203. PubMed ID: 7590780 [TBL] [Abstract][Full Text] [Related]
35. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for Zettlitz KA; Waldmann CM; Tsai WK; Tavaré R; Collins J; Murphy JM; Wu AM J Nucl Med; 2019 Oct; 60(10):1467-1473. PubMed ID: 30877181 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and pre-clinical evaluation of a new class of high-affinity Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991 [TBL] [Abstract][Full Text] [Related]
37. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma]. Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335 [TBL] [Abstract][Full Text] [Related]
38. Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody. Sakahara H; Hosono M; Kobayashi H; Yao Z; Saga T; Yano S; Endo K; Mori T; Konishi J Jpn J Cancer Res; 1996 Jun; 87(6):655-61. PubMed ID: 8766531 [TBL] [Abstract][Full Text] [Related]
39. The application value of the detection of the level of tissue polypeptide antigen, ovarian cancer antigen X1, cathepsin L and CA125 on the diagnosis of epithelial ovarian cancer. Lv XL; Zhu Y; Liu JW; Ai H Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5113-5116. PubMed ID: 28051260 [TBL] [Abstract][Full Text] [Related]
40. Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer. Sasaki A; Akita K; Ito F; Mori T; Kitawaki J; Nakada H Int J Cancer; 2015 Apr; 136(8):1985-90. PubMed ID: 25197000 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]